Company Filing History:
1 out of 9 
1 out of 3,107 
Years Active: 2020
Title: Chuantao Zha: Innovator in FGFR Kinase Inhibition
Introduction
Chuantao Zha is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit FGFR kinase activity. His work is crucial for advancing treatments for diseases related to FGFR kinase.
Latest Patents
Chuantao Zha holds a patent for "Indazole compounds as FGFR kinase inhibitor, preparation and use thereof." This invention provides an indazole compound that acts as a FGFR kinase inhibitor. The compound, represented by a specific formula, demonstrates good FGFR kinase-inhibiting activity and can be utilized in preparing medicines for treating diseases associated with FGFR kinase activity. He has 1 patent to his name.
Career Highlights
Throughout his career, Chuantao Zha has worked with notable organizations, including Shanghai Haihe Pharmaceutical Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Chuantao Zha has collaborated with several professionals in his field, including Meiyu Geng and Lei Liu. These collaborations have contributed to the advancement of his research and the successful development of innovative compounds.
Conclusion
Chuantao Zha is a key figure in the field of FGFR kinase inhibition, with a focus on developing effective medicinal compounds. His contributions are vital for the ongoing research and treatment of related diseases.